Castleark Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-87,660	Closed	-$2.77M	–	384
2018 Q3	$2.77M	Sell	87,660 -113,420	-56%	-$3.59M	0.08%	227
2018 Q2	$7.81M	Buy	201,080 +141,505	+238%	+$5.5M	0.24%	134
2018 Q1	$1.64M	Buy	+59,575	New	+$1.64M	0.05%	260